Company intelligence / Profile preview

IMADIS Technologies et Services

Lyon, France

Ownership: Private
Employees: ~159
Development stage: Other

Overview

IMADIS operates 24/7 teleradiology services with AI integration. AI corrections occur in 0.5% of intracranial hemorrhage cases and 1% of pulmonary embolism cases. AI fracture detection solutions could reduce missed fractures by 30%.

Therapeutic areas: Other
Industry: Medical Imaging

Partnerships

Aidoc (Israeli AI company for intracranial hemorrhage and pulmonary embolism detection)Gleamer (French Medtech for fracture detection via BoneView solution)Deeplink Medical (ITIS platform developer)

Beyond the preview

Go deeper on IMADIS Technologies et Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMADIS Technologies et Services.

Explore the full profile